“…Numerous experimental studies, including recent studies from our group, have demonstrated the potential of exogenously or endogenously derived stem cells alone or in combination with in situ tissue engineering strategies and/or pharmacotherapeutics in promoting transplant‐mediated repair with functional restoration through such diverse mechanisms as neuroprotection, cell replacement, remyelination, tissue/vascular remodelling and de novo neurogenesis (Augestad et al., ; Bible et al., ; Jendelová et al., ; Kokaia & Lindvall, ; Lindvall & Kokaia, ; Massensini et al., ; Medberry et al., ; Sandvig et al., ). Although highly promising and extremely valuable in elucidating relevant recovery mechanisms at the experimental level, clinical translation of such approaches tends to be confounded by significant challenges, such as allograft rejection as well as the intricacies inherent in trying to create safe, functional in situ biointerfaces that could effectively re‐establish functional connectivity in multiple foci (Sandvig et al., ).…”